Evolution of the sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: Need for improvement of current poliovirus surveillance

Journal of Virology

Volumn 83, Issue 7, 2009, Pages 3402-3406

  Yakovenko, Maria L ^a   Korotkova, Ekaterina A ^a   Ivanova, Olga E ^b   Eremeeva, Tatyana P ^b   Samoilovich, Elena ^c   Uhova, Iryna ^c   Gavrilin, Gene V ^d   Agol, Vadim I ^a,b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

^c Ministry of Health Republic of Belarus   (Belarus)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ORAL POLIOMYELITIS VACCINE; VIRUS RNA;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CASE REPORT; CAUSAL ATTRIBUTION; CHILD; DRUG ANTIGENICITY; EVOLUTION; FECES ANALYSIS; GENE STRUCTURE; GENETIC VARIABILITY; HUMAN; IMMUNOASSAY; INFANT; MALE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION; VIRUS VIRULENCE; CHEMICAL STRUCTURE; CONFORMATION; DNA SEQUENCE; GENETICS; IMMUNOLOGY; MISSENSE MUTATION; MOLECULAR GENETICS; PATHOGENICITY; POINT MUTATION; VIROLOGY; VIRULENCE;

POLIOVIRUS;

CHILD, PRESCHOOL; EVOLUTION, MOLECULAR; HUMANS; INFANT; MALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NUCLEIC ACID CONFORMATION; POINT MUTATION; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRULENCE;

EID: 63149124931     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02122-08     Document Type: Article

References (29)

1. Adu, F., J. Iber, D. Bukbuk, N. Gumede, S. J. Yang, J. Jorba, R. Campagnoli, W. F. Sule, C. F. Yang, C. Burns, M. Pallansch, T. Harry, and O. Kew. 2007. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. Vims Res. 127:17-25.
2. Agol, V. I. 2006. Molecular mechanisms of poliovirus variation and evolution. Curr. Top. Microbiol. Immunol. 299:211-259.
3. Agol, V. I. 2006. Vaccine-derived polioviruses. Biologicals 34:103-108.
4. Balanant, J., S. Guillot, A. Candrea, F. Delpeyroux, and R. Crainic. 1991. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 184:645-654.
5. Burns, C. C., J. Shaw, R. Campagnoli, J. Jorba, A. Vincent, J. Quay, and O. Kew. 2006. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. J. Virol. 80:3259-3272.
6. Buttinelli, G., V. Donati, S. Fiore, J. Marturano, A. Plebani, P. Balestri, A. R. Soresina, R. Vivarelli, F. Delpeyroux, J. Martin, and L. Fiore. 2003. Nucle-otide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J. Gen. Virol. 84:1215-2121.
7. Cherkasova, E. A., M. Laassri, V. Chizhikov, E. Korotkova, E. Dragunsky, V. I. Agol, and K. Chumakov. 2003. Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived poliovirases. Proc. Natl. Acad. Sci. USA 100:9398-9403.
8. Cherkasova, E. A., M. L. Yakovenko, G. V. Rezapkin, E. A. Korotkova, O. E. Ivanova, T. P. Eremeeva, L. I. Krasnoproshina, N. I. Romanenkova, N. R. Rozaeva, L. Sirota, V. I. Agol, and K. M. Chumakov. 2005. Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine. J. Virol. 79:1062-1070.
9. Chumakov, K., E. Ehrenfeld, E. Wimmer, and V. I. Agol. 2007. Vaccination against polio should not be stopped. Nature Rev. Microbiol. 5:952-958.
10. Coleman, J. R., D. Papamichail, S. Skiena, B. Futcher, E. Wimmer, and S. Mueller. 2008. Virus attenuation by genome-scale changes in codon pair bias. Science 320:1784-1787.
11. Crainic, R., B. Blondel, and F. Horaud. 1984. Antigenic variation of poliovirus studied by means of monoclonal antibodies. Rev. Infect. Dis. 6(Suppl. 2):S535-S539.
12. Ehrenfeld, E., R. I. Glass, V. I. Agol, K. Chumakov, W. Dowdle, T. J. John, S. L. Katz, M. Miller, J. G. Breman, J. Modlin, and P. Wright. 2008. Polio immunization: moving forward. Lancet 371:1385-1387.
13. Gavrilin, G. V., E. A, Cherkasova, G. Y. Lipskaya, O. M. Kew, and V. I. Agol. 2000. Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J. Virol. 74:7381-7390.
14. Kew, O. M, R. W. Sutter, E. M. de Gourville, W. R. Dowdle, and M. A, Pallansch. 2005. Vaccine-derived poliovirases and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59:587-635.
15. Korotkova, E. A., R. Park, E. A. Cherkasova, G. Y. Lipskaya, K. M. Chumakov, E. V. Feldman, O. M. Kew, and V. I. Agol. 2003. Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future. J. Virol. 77:12460-12465.
16. Minor, P. D. 1990. Antigenic structure of picornaviruses. Curr. Top. Microbiol. Immunol. 161:121-154.
17. Muzychenko, A, R., G. Y. Lipskaya, S. V. Maslova, Y. V. Svitkin, E. V. Pilipenko, B. K. Nottay, O. M. Kew, and V. I. Agol. 1991. Coupled mutations in the 5′-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Res. 21:111-122.
18. Pilipenko, E. V., V. M. Blinov, L. I. Romanova, A. N. Sinyakov, S. V. Maslova, and V. I. Agol. 1989. Conserved structural domains in the 5′-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology 168:201-209.
19. Rakoto-Andrianarivelo, M., S. Guillot, J. Iber, J. Balanant, B. Blondel, F. Riquet, J. Martin, O. Kew, B. Randriamanalina, L. Razafinimpiasa, D. Rousset, and F. Delpeyroux. 2007. Co-circulation and evolution of poliovirases and species C enteroviruses in a district of Madagascar. PLoS Pathog. 3:e191.
20. Romanenkova, N. I., S. Guillot, N. R. Rozaeva, R. Crainic, M. A. Bichurina, and F. Delpeyroux. 2006. Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived poliovirases in clinical samples. J. Clin. Microbiol. 44:4077-4084.
21. Shulman, L. M., Y. Manor, R. Handsher, F. Delpeyroux, M. J. McDonough, T. Halmut, I. Silberstein, J. Alfandari, J. Quay, T. Fisher, J. Robinov, O. M. Kew, R. Crainic, and E. Mendelson. 2000. Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J. Clin. Microbiol. 38:3729-3734.
22. Shulman, L. M., Y. Manor, D. Sofer, R. Handsher, T. Swartz, F. Delpeyroux, and E. Mendelson. 2006. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. PLoS ONE 1:e69.
23. World Health Assembly. 1988. Polio eradication by the year 2000. Resolution 41.28. World Health Organization, Geneva, Switzerland.
24. World Health Organization. 2004. Polio laboratory manual, 4th ed. (WHO/IVB/04.10). World Health Organization, Geneva, Switzerland.
25. World Health Organization. 2007. Global update on vaccine-derived polioviruses, January 2006-August 2007. Wkly. Epidemiol. Rec. 82:337-344.
26. World Health Organization. 2008. Informal consultation of the Global Polio Laboratory Network. Wkly. Epidemiol. Rec. 83:261-268.
27. Yakovenko, M. L., E. A. Cherkasova, G. V. Rezapkin, O. E. Ivanova, A. P. Ivanov, T. P. Eremeeva, O. Y. Baykova, K. M. Chumakov, and V. I. Agol. 2006. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J. Virol. 80:2641-2653.
28. Yang, C. F., H. Y. Chen, J. Jorba, H. C. Sun, S. J. Yang, H. C. Lee, Y. C. Huang, T. Y. Lin, P. J. Chen, H. Shimizu, Y. Nishimura, A. Utama, M. Pallansch, T. Miyamura, O. Kew, and J. Y. Yang. 2005. Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J. Virol. 79: 12623-12634.
29. Yang, C. F., T. Naguib, S. J. Yang, E. Nasr, J. Jorba, N. Ahmed, R. Camp-agnoli, H. van der Avoort, H. Shimizu, T. Yoneyama, T. Miyamura, M. Pallansch, and O. Kew. 2003. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J. Virol. 77:8366-8377.